LifeScience Biologics
Recommendation for approval based on Phase 3 KarMMa-3 study in which Abecma demonstrated superiority over standard regimens, significantly improv...
January 26, 2024 | News
In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...
January 26, 2024 | Interview
The move represents a significant leap in innovation for Ceva, unlocking access to key advancements including a pipeline of monoclonal antibodies and ...
January 26, 2024 | News
US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 emp...
January 26, 2024 | News
The study aims to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary anti-tumoral activity of OT-A201. The study is a Eur...
January 25, 2024 | News
Merck announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company&rsq...
January 24, 2024 | News
Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP m...
January 24, 2024 | News
RT-qPCR is commonly performed to support gene expression analysis, which compares the expression of genes between two or more samples and can help ...
January 23, 2024 | News
In an insightful interaction with BioPharma APAC, Joanne Tsarouha, Sr. Product Manager of Microarray Technology at Thermo Fisher Scientific, delves into th...
January 24, 2024 | Expert Insight
The foreign patient was first diagnosed with multiple myeloma in 2008. Despite multiple treatments including chemotherapy, immunotherapy, target treatment,...
January 23, 2024 | News
This partnership leverages LOTTE BIOLOGICS' extensive proficiency in antibody manufacturing and NJ Bio's specialized skills in ADC process development, as ...
January 22, 2024 | News
Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (A...
January 19, 2024 | News
To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the laun...
January 18, 2024 | News
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline...
January 17, 2024 | News
Most Read
Bio Jobs
News
Editor Picks